These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 10668858)

  • 21. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
    Yamazaki H; Shimada T
    Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4.
    Zhou S; Chan E; Lim LY; Boelsterli UA; Li SC; Wang J; Zhang Q; Huang M; Xu A
    Curr Drug Metab; 2004 Oct; 5(5):415-42. PubMed ID: 15544435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil.
    Hyland R; Roe EG; Jones BC; Smith DA
    Br J Clin Pharmacol; 2001 Mar; 51(3):239-48. PubMed ID: 11298070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam.
    van Waterschoot RA; Rooswinkel RW; Sparidans RW; van Herwaarden AE; Beijnen JH; Schinkel AH
    Drug Metab Dispos; 2009 Dec; 37(12):2305-13. PubMed ID: 19752211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of CYP3A4 inhibition by grapefruit juice and ketoconazole upon clozapine administration in vivo.
    Lane HY; Chiu CC; Kazmi Y; Desai H; Lam YW; Jann MW; Chang WH
    Drug Metabol Drug Interact; 2001; 18(3-4):263-78. PubMed ID: 11791889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man.
    Kupferschmidt HH; Fattinger KE; Ha HR; Follath F; Krähenbühl S
    Br J Clin Pharmacol; 1998 Apr; 45(4):355-9. PubMed ID: 9578182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4.
    Zhou SF
    Curr Drug Metab; 2008 May; 9(4):310-22. PubMed ID: 18473749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole.
    Kivistö KT; Lamberg TS; Kantola T; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Sep; 62(3):348-54. PubMed ID: 9333111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolongation of the QT interval related to cisapride-diltiazem interaction.
    Thomas AR; Chan LN; Bauman JL; Olopade CO
    Pharmacotherapy; 1998; 18(2):381-5. PubMed ID: 9545159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance.
    Fuhr U
    Drug Saf; 1998 Apr; 18(4):251-72. PubMed ID: 9565737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation.
    Mayhew BS; Jones DR; Hall SD
    Drug Metab Dispos; 2000 Sep; 28(9):1031-7. PubMed ID: 10950845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir.
    Gutierrez MM; Rosenberg J; Abramowitz W
    Clin Ther; 2003 Apr; 25(4):1200-10. PubMed ID: 12809966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of correlation between in vitro inhibition of CYP3A-mediated metabolism by a PPAR-gamma agonist and its effect on the clinical pharmacokinetics of midazolam, an in vivo probe of CYP3A activity.
    Fayer JL; Zannikos PN; Stevens JC; Luo Y; Sidhu R; Kirkesseli S
    J Clin Pharmacol; 2001 Mar; 41(3):305-16. PubMed ID: 11269571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition selectivity of grapefruit juice components on human cytochromes P450.
    Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y
    Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro.
    Eagling VA; Wiltshire H; Whitcombe IW; Back DJ
    Xenobiotica; 2002 Jan; 32(1):1-17. PubMed ID: 11824416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic interactions between etravirine and non-antiretroviral drugs.
    Kakuda TN; Schöller-Gyüre M; Hoetelmans RM
    Clin Pharmacokinet; 2011 Jan; 50(1):25-39. PubMed ID: 21142266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol.
    Swaisland HC; Ranson M; Smith RP; Leadbetter J; Laight A; McKillop D; Wild MJ
    Clin Pharmacokinet; 2005; 44(10):1067-81. PubMed ID: 16176119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients.
    Furukori H; Kondo T; Yasui N; Otani K; Tokinaga N; Nagashima U; Kaneko S; Inoue Y
    Psychopharmacology (Berl); 1999 Jul; 145(2):189-92. PubMed ID: 10463320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism.
    Fitzsimmons ME; Collins JM
    Drug Metab Dispos; 1997 Feb; 25(2):256-66. PubMed ID: 9029057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors.
    Terkeltaub RA; Furst DE; Digiacinto JL; Kook KA; Davis MW
    Arthritis Rheum; 2011 Aug; 63(8):2226-37. PubMed ID: 21480191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.